SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Pfizer enters exclusive licensing agreement with Starna Therapeutics

Pfizer entered an exclusive licensing agreement with Starna Therapeutics for autoimmune diseases.

PFE

Story updates

11:45:11 AM UTC
SquawkNews
Pfizer Inc. (NYSE:PFE) today announced that it entered into an exclusive licensing agreement with Starna Therapeutics, a biotechnology company developing RNA medicines designed to enable in vivo therapeutics. Under the agreement, Pfizer obtains exclusive rights outside Greater China to develop, man…
11:45:25 AM UTC
SquawkNews
Pfizer obtained exclusive rights outside Greater China to develop, manufacture and commercialize three pre-IND in vivo CAR-T programs focused on autoimmune diseases. Financial terms were not disclosed.Material DetailsContext by AI AnalystThis is an early-stage pipeline expansion, with all three lic…
11:46:30 AM UTC
SquawkNews
Pfizer entered an exclusive licensing agreement for three pre-IND in vivo CAR-T programs for autoimm

Related stories